首页|补中益气汤含药血清抑制肺癌细胞活性及血管生成拟态的机制研究

补中益气汤含药血清抑制肺癌细胞活性及血管生成拟态的机制研究

扫码查看
目的 探讨补中益气汤含药血清对肺癌细胞活性及血管生成拟态(VM)的影响及机制。方法 通过SD大鼠灌胃法制备低剂量(BZ-L组)、中等剂量(BZ-M组)、高剂量(BZ-H组)补中益气汤含药血清,进行肺癌细胞干预。通过CCK-8实验、Edu细胞增殖实验、细胞克隆形成实验及细胞划痕实验、Transwell实验检测补中益气汤对肺癌A549、HCC827细胞增殖及迁移的影响。采用流式细胞术检测补中益气汤对肺癌细胞凋亡和细胞周期的影响,通过体外VM实验检测补中益气汤对肺癌细胞血管生成的影响。通过RNA-seq测序检测对照组细胞与药物干预细胞的差异表达基因。构建小鼠皮下移植瘤,检测补中益气汤灌胃治疗对肺癌细胞体内生长的抑制作用。结果 补中益气汤可呈剂量依赖性地抑制A549、HCC827细胞的活力和增殖活性,并可呈剂量依赖性地促进肺癌细胞凋亡,诱导细胞发生G2/M期阻滞。经补中益气汤干预后,A549、HCC827细胞的迁移能力显著减弱。随着补中益气汤干预浓度的提高,A549细胞及HCC827细胞的VM逐渐减少。与对照组细胞相比,补中益气汤组细胞有765个差异表达基因,其中p-JNK和p-ERKl/2基因表达显著下调。Western blot检测结果显示,随着补中益气汤浓度的升高,A549、HCC827细胞中 JNK/ERK1/2信号通路的磷酸化水平被逐渐抑制。补中益气汤可使小鼠肿瘤的体积和质量均显著减小,使肿瘤组织中细胞凋亡率升高,并使肿瘤组织中p-JNK、p-ERK1、p-ERK2表达降低和E-cadherin表达升高。结论 补中益气汤可能通过抑制JNK/ERK1/2信号通路活性,抑制肺癌细胞活性和血管生成。
Mechanism of drug-containing serum of Buzhong Yiqi Decoction in inhibiting the activity and vasculogenic mimicry of lung cancer cells
Objective To investigate the effects and mechanisms of drug-containing serum of Buzhong Yiqi Decoction on the activity and vasculogenic mimicry(VM)of lung cancer cells.Meth-ods Drug-containing serum of Buzhong Yiqi Decoction with low-dose(BZ-L group),medium-dose(BZ-M group),and high-dose(BZ-H group)were prepared through gastric lavage in SD rats to inter-vene lung cancer cells.CCK-8 assay,Edu cell proliferation assay,cell clone formation assay,cell scratch assay,and Transwell assay were used to detect the effects of Buzhong Yiqi Decoction on the proliferation and migration of lung cancer A549 and HCC827 cells.Flow cytometry was employed to detect the impacts of Buzhong Yiqi Decoction on lung cancer cell apoptosis and cell cycle,and VM ex-periments in vitro were conducted to assess the effect of Buzhong Yiqi Decoction on angiogenesis in lung cancer cells.Differentially expressed genes between control cells and drug-intervened cells were detected by RNA-seq sequencing.Subcutaneous xenografts in mice were established to evaluate the in-hibitory effect of gavage therapy of Buzhong Yiqi Decoction on the growth of lung cancer cells in vivo.Results Buzhong Yiqi Decoction inhibited the viability and proliferative activity of A549 and HCC827 cells in a dose-dependent manner,promoted lung cancer cell apoptosis in a dose-dependent manner,and induced G2/M phase arrest.The migration ability of A549 and HCC827 cells was significantly reduced after Buzhong Yiqi Decoction intervention.As the concentration of Buzhong Yiqi Decoction increased,the VM of A549 and HCC827 cells gradually decreased.Compared with control cells,765 differentially expressed genes were identified in the Buzhong Yiqi Decoction group,with signifi-cant downregulation of p-JNK and p-ERK1/2 gene expression.Western blot analysis revealed that the phosphorylation level of the JNK/ERK1/2 signaling pathway in A549 and HCC827 cells was gradually inhibited with increasing concentrations of Buzhong Yiqi Decoction.Buzhong Yiqi Decoc-tion significantly reduced the volume and mass of mouse tumors,increased the apoptosis rate in tumor tissues,decreased the expression of p-JNK,p-ERK1,and p-ERK2,and increased the expression of E-cadherin in tumor tissues.Conclusion Buzhong Yiqi Decoction may inhibit the activity and angio-genesis of lung cancer cells by suppressing the activity of the JNK/ERK1/2 signaling pathway.

lung cancerBuzhong Yiqi Decoctionanticancercell activityvasculogenic mimicry

田芳、韩硕、王翠、孟静

展开 >

河北省保定市第一中医院,河北保定,071000

肺癌 补中益气汤 抑癌 细胞活性 血管生成拟态

河北省医学科研课题计划项目

0200264

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(6)
  • 17